CLINICAL_TRIALS trial_result · 2022-05-27

Clinical Trial Update: A Study to Assess Efficacy, Long Term Safety and Tolerability of RT001 in Subjects With Friedreich's Ataxia [Phase 3]

Phase 3 trial assessing efficacy, long-term safety, and tolerability of RT001 in Friedreich's Ataxia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Biojiva LLC | Conditions: Friedreich's Ataxia | Phase 3 | Status: COMPLETED | Results posted: 2022-05-27